Exhale

The official blog of the Lung Institute.

Is Bronchiectasis Reversible?

22 Aug 2017
| Under Bronchiectasis | Posted by | 4 Comments
Is Bronchiectasis Reversible?

Bronchiectasis is a chronic obstructive respiratory condition that can lead to serious lung damage. Over time, inflammation in the airways (bronchi) can cause the walls of the bronchi to thicken, which can interfere with the proper drainage of mucus and, in turn, allow bacteria to accumulate and thrive. When left untreated, bronchiectasis can produce recurrent infections, persistent coughing and permanent lung scarring.

Currently, there is no cure for bronchiectasis. However, there are treatments available that can relieve its symptoms, slow its progression and help preserve lung function. Traditional forms of treatment, such as bronchodilators and antibiotic medications, generally focus on reducing inflammation, thinning mucus, improving air flow and treating infection. Sometimes, if the damage is confined to a small area of a lung, surgery may be recommended to address very severe symptoms.

Alternatively, the Lung Institute offers cellular therapy for bronchiectasis treatment:

  • Blood-derived cellular therapy

These minimally invasive, outpatient procedures are designed to take advantage of the unique and powerful capabilities of adult cells. After deriving a sample of a patient’s blood, our regenerative medicine specialists isolate the cells in our on-site lab. When reintroduced to the patient’s body intravenously, the highly concentrated cells can travel through the bloodstream to reach the lungs and promote the natural healing of damaged tissue.

As the world’s only cellular therapy center that focuses exclusively on treating pulmonary conditions – some of which are considered to be irreversible – the Lung Institute helps many people manage their bronchiectasis symptoms and achieve a better quality of life. We understand that our patients are individuals, and we believe they deserve treatments that meet their unique needs and goals.

Contact the Lung Institute today at (800) 729-3065 to learn more about our innovative cellular therapies for bronchiectasis.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.